Mercator Medical S.A. (WSE:MRC)

Mercator Medical Statistics

Total Valuation

WSE:MRC has a market cap or net worth of PLN 412.31 million. The enterprise value is 234.44 million.

Market Cap	412.31M
Enterprise Value	234.44M

Important Dates

The last earnings date was Monday, September 29, 2025.

Earnings Date	Sep 29, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:MRC has 9.77 million shares outstanding. The number of shares has decreased by -1.73% in one year.

Current Share Class	6.94M
Shares Outstanding	9.77M
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.89%
Float	3.89M

Valuation Ratios

The trailing PE ratio is 5.92.

PE Ratio	5.92
Forward PE	n/a
PS Ratio	0.71
PB Ratio	0.46
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	3.53
EV / Sales	0.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.53

Financial Position

The company has a current ratio of 8.04, with a Debt / Equity ratio of 0.03.

Current Ratio	8.04
Quick Ratio	4.14
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-64.70

Financial Efficiency

Return on equity (ROE) is 7.63% and return on invested capital (ROIC) is -1.64%.

Return on Equity (ROE)	7.63%
Return on Assets (ROA)	-1.47%
Return on Invested Capital (ROIC)	-1.64%
Return on Capital Employed (ROCE)	-2.50%
Revenue Per Employee	610,348
Profits Per Employee	69,852
Employee Count	950
Asset Turnover	0.59
Inventory Turnover	2.48

Taxes

Income Tax	-22.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.91% in the last 52 weeks. The beta is 0.17, so WSE:MRC's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-24.91%
50-Day Moving Average	44.61
200-Day Moving Average	46.29
Relative Strength Index (RSI)	33.31
Average Volume (20 Days)	7,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:MRC had revenue of PLN 579.83 million and earned 66.36 million in profits. Earnings per share was 7.12.

Revenue	579.83M
Gross Profit	156.13M
Operating Income	-23.16M
Pretax Income	44.11M
Net Income	66.36M
EBITDA	-2.32M
EBIT	-23.16M
Earnings Per Share (EPS)	7.12

Balance Sheet

The company has 198.66 million in cash and 23.81 million in debt, giving a net cash position of 174.85 million or 17.90 per share.

Cash & Cash Equivalents	198.66M
Total Debt	23.81M
Net Cash	174.85M
Net Cash Per Share	17.90
Equity (Book Value)	891.36M
Book Value Per Share	91.54
Working Capital	524.00M

Cash Flow

In the last 12 months, operating cash flow was -117.48 million and capital expenditures -36.22 million, giving a free cash flow of -153.70 million.

Operating Cash Flow	-117.48M
Capital Expenditures	-36.22M
Free Cash Flow	-153.70M
FCF Per Share	-15.73

Margins

Gross margin is 26.93%, with operating and profit margins of -3.99% and 11.44%.

Gross Margin	26.93%
Operating Margin	-3.99%
Pretax Margin	7.61%
Profit Margin	11.44%
EBITDA Margin	-0.40%
EBIT Margin	-3.99%
FCF Margin	n/a

Dividends & Yields

WSE:MRC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.73%
Shareholder Yield	n/a
Earnings Yield	16.09%
FCF Yield	-37.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:MRC has an Altman Z-Score of 5 and a Piotroski F-Score of 3.

Altman Z-Score	5
Piotroski F-Score	3